In a filing, Resmed Inc revealed its Chief Executive Officer Farrell Michael J. unloaded Company’s shares for reported $2.06 million on Jul 07 ’25. In the deal valued at $256.72 per share,8,009 shares were sold. As a result of this transaction, Farrell Michael J. now holds 455,503 shares worth roughly $115.88 million.
Then, Farrell Michael J. bought 8,009 shares, generating $2,056,076 in total proceeds.
Before that, FARRELL PETER C sold 945 shares. Resmed Inc shares valued at $241,438 were divested by the Director at a price of $255.49 per share. As a result of the transaction, FARRELL PETER C now holds 68,273 shares, worth roughly $17.37 million.
Morgan Stanley initiated its Resmed Inc [RMD] rating to an Overweight in a research note published on March 19, 2025; the price target was $280. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in mid March with a ‘”an Overweight”‘ rating. Goldman began covering RMD with “Buy” recommendation on January 16, 2025. Piper Sandler started covering the stock on January 10, 2025. It rated RMD as “a Neutral”.
Price Performance Review of RMD
On Friday, Resmed Inc [NYSE:RMD] saw its stock fall -1.42% to $254.4. Over the last five days, the stock has lost -1.00%. Resmed Inc shares have risen nearly 33.66% since the year began. Nevertheless, the stocks have risen 11.24% over the past one year. While a 52-week high of $263.05 was reached on 01/30/25, a 52-week low of $195.00 was recorded on 04/07/25.
Levels Of Support And Resistance For RMD Stock
The 24-hour chart illustrates a support level at 252.18, which if violated will result in even more drops to 249.96. On the upside, there is a resistance level at 257.08. A further resistance level may holdings at 259.75.
How much short interest is there in Resmed Inc?
A steep rise in short interest was recorded in Resmed Inc stocks on 2025-06-13, dropping by -1.01 million shares to a total of 9.93 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 10.93 million shares. There was a decline of -10.12%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 13, 2024 when Stifel began covering the stock and recommended ‘”a Hold”‘ rating along with a $250 price target.
